Victoria instructions for use
The drug is available as a disposable pen - a syringe. It is designed to lower blood sugar in patients who have a history of type 2 diabetes. Victoria is used both in combination with diet and individually selected physical exercises, and in combination with other drugs to control the glycemic level.
Form of issue and composition
The substance of liraglutide is considered to be an active active ingredient. Its content in 1 ml reaches 6 mg. One syringe-pen has a volume of drug of 3 ml, which contains 18 mg of liraglutide. The auxiliary components are represented by propylene glycol, hydrochloric acid, phenol, sodium hydrogen phosphate dihydrate, water for injection.
Secondary cartons may contain 3, 2 or 1 syringes - a pen made of plastic. The kit also includes detailed instructions.
Indications for use
The drug Victoria is assigned to control the level of sugar in the blood in patients with type 2 diabetes. Can be combined with metformin or other drugs as directed by your doctor.
It is impossible to appoint Victoria under such conditions and diseases:
- increased sensitivity to both the main acting component and to any of the auxiliary elements;
- the period of breastfeeding;
- diabetic ketoacidosis;
- liver failure;
- Type 1 diabetes;
- malfunctions in the urinary system;
- heart failure;
- age to 18 years;
- paresis of the stomach;
- intestinal inflammatory diseases.
Caution is required in the therapy of Victoria in patients with heart failure class 1 - 2, not pronounced lesions of the kidney or liver, as well as in patients older than 75 years of age.
Dosing and Administration
Convenience of use is the use of the drug once for 24 hours. Injection is permitted to be performed subcutaneously in the thigh, shoulder, or abdomen. Execution of the injection is not dependent on food intake. It is desirable to observe the intervals between injections. The solution is prohibited to be administered intravenously and intramuscularly.
At the beginning of therapy, the dosage is 0.6 mg liraglutide for 24 hours. At least after 7 days of use, the dose is increased to 1.2 mg per day. There is information that the effectiveness of treatment especially often appears when a dose is prescribed in the range 1.2 - 1.8 mg for 24 hours. The dose of 1.8 mg also occurs after 7 days of application of a dose of 1.2 mg. It is undesirable to exceed the daily dosage of 1.8 mg of liraglutide.
Often, Victoria is combined with metformin or other drugs. The correct dosage of these drugs should be discussed in addition with the attending physician.
Patients are periodically assigned blood tests, especially with Victoria therapy in combination with other medications.
In the elderly, the dosage does not differ from the above. Only patients older than 75 years need increased attention in the treatment of the drug.
With renal failure, which is mild, dose adjustment is not needed. With renal failure of a severe stage, Victoria is contraindicated. Also, no remedy is prescribed for all stages of liver failure.
Until 18 years old, Victoria is not appointed. There are no data on its use in this age group.
It is not used in the treatment of patients with type 1 diabetes and diabetic ketoacidosis. Data on the use of Victoria in the treatment of patients with different degrees of heart failure are absent. There is no information about side effects in people with intestinal inflammatory diseases and gastric paresis. In these groups, Victoria's treatment is contraindicated.
Therapy with this drug can cause short-term negative manifestations in the form of dyspeptic complications. There is a possibility of pancreatitis . Cases of pancreatitis in the acute stage were recorded. Its development is indicated by persistent pain of strong manifestation in the gastrointestinal tract. In this case, treatment with Victoria is immediately stopped.
During the drug tests, there were reports of malfunctions in the thyroid gland (changes in hormonal analysis, development of neoplasms, goitre, especially in people who had problems with this organ before the therapy).
The likelihood of hypoglycemia with a combination of derivatives of sulfonylurea and Victoria is increased. It is necessary to adjust the dose of concomitant drugs.
Data on the influence of Victoria on pregnant women are absent. However, in studies on animals, it was found that the drug has reproductive toxicity. When pregnancy is recommended for insulin therapy, Victoria is contraindicated. If the pregnancy is only planned or the time is short, then injections of Victoria are prohibited. They must be stopped immediately.
The penetration of liraglutide into the milk of lactating women is low, however, at this time, Victoria is not assigned.
Terms and conditions of storage
The storage term is 30 months. It is stored only in the refrigerator at temperature values from 2 to 8 degrees. Must be kept away from children. Do not freeze.
Currently there are no analogues of Victoria.
Victoria injection for 6mg / ml 3ml - 10000-11500 rub.